Fidelity Investments’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $348K | Sell |
511,820
-372,215
| -42% | -$253K | ﹤0.01% | 3107 |
|
|
2025
Q1 | $640K | Sell |
884,035
-511,818
| -37% | -$371K | ﹤0.01% | 2834 |
|
|
2024
Q4 | $1.33M | Hold |
1,395,853
| – | – | ﹤0.01% | 2574 |
|
|
2024
Q3 | $1.1M | Hold |
1,395,853
| – | – | ﹤0.01% | 2568 |
|
|
2024
Q2 | $1.32M | Sell |
1,395,853
-511,818
| -27% | -$485K | ﹤0.01% | 2445 |
|
|
2024
Q1 | $2.06M | Hold |
1,907,671
| – | – | ﹤0.01% | 2325 |
|
|
2023
Q4 | $1.05M | Hold |
1,907,671
| – | – | ﹤0.01% | 2463 |
|
|
2023
Q3 | $4.03M | Hold |
1,907,671
| – | – | ﹤0.01% | 2105 |
|
|
2023
Q2 | $5M | Hold |
1,907,671
| – | – | ﹤0.01% | 2065 |
|
|
2023
Q1 | $6.07M | Hold |
1,907,671
| – | – | ﹤0.01% | 2031 |
|
|
2022
Q4 | $5.13M | Sell |
1,907,671
-312,091
| -14% | -$840K | ﹤0.01% | 2109 |
|
|
2022
Q3 | $6.46M | Sell |
2,219,762
-301,571
| -12% | -$878K | ﹤0.01% | 2083 |
|
|
2022
Q2 | $7.36M | Sell |
2,521,333
-69,389
| -3% | -$203K | ﹤0.01% | 2106 |
|
|
2022
Q1 | $18.3M | Buy |
2,590,722
+20,452
| +0.8% | +$145K | ﹤0.01% | 1819 |
|
|
2021
Q4 | $41.1M | Buy |
+2,570,270
| New | +$41.1M | ﹤0.01% | 1498 |
|